Phase III data: STELARA reduces active psoriatic arthritis

Singapore: A study by Janssen Research and Development revealed that patients with active psoriatic arthritis, who were ...

June 6, 2012 | Wednesday | News
Lonza, BioWa sign research agreements with Pfizer

Singapore: Swiss chemicals and drug company Lonza and USA-based BioWa, a wholly-owned subsidiary of Japan's Kyowa Hakko ...

July 31, 2013 | Wednesday | News
FDA recommends Takeda's drug for Chrohn's disease

Singapore: A joint panel of members from the Gastrointestinal Drugs and Drug Safety and Risk Management Advisory Committ...

April 24, 2014 | Thursday | Regulatory
Patrys gets regulatory approval for Multiple Myeloma trial

Singapore: Australia Patrys, a clinical stage biopharmaceutical company, has received approval to commence its planned P...

September 20, 2012 | Thursday | News
Novartis follows Time Warner, Twitter to join malaria campaign

Singapore: Novartis and Malaria No More, a leading global charity to end malaria deaths, are joining forces on the Power...

April 25, 2013 | Thursday | News
NIH: Alcohol addiction depends on gene combination

Singapore: An experimental treatment for alcohol dependence works better in individuals who possess specific combination...

August 5, 2013 | Monday | News
Merck partners with Kenya research centre

Singapore: Merck has partnered with Kenya Medical Research Institution (KEMRI) for scientific research and development p...

October 30, 2014 | Thursday | News
Shionogi partners with six Irish universities

Singapore: Shionogi, one of Japan's biggest pharmaceutical companies, has signed a memorandum of understanding (MoU) for...

June 19, 2013 | Wednesday | News
Merck alzheimer's trial is a success

Singapore: Merck, which is known as MSD outside the US and Canada, revealed positive results from its phase Ib study sho...

July 16, 2013 | Tuesday | News
Viralytics multi-cancer drug shows +ve results

Singapore: Viralytics has finalized the clinical study report on the phase I evaluation of Cavatak, which is administere...

April 9, 2013 | Tuesday | News
Forest to acquire rights to Merck's Saphris

Singapore: US based Forest Laboratories plans to acquire exclusive rights in the United States for Saphris (asenapine) s...

December 5, 2013 | Thursday | News
FDA approves GSK meningococcal vaccine

Singapore: The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's vaccine MenHibrix (meningococcal gr...

June 15, 2012 | Friday | News
Patrys gets 2nd Aus patent for cancer drug

Singapore: Australia-based Patrys, a clinical stage biotechnology company, has been granted a second Australian patent f...

November 19, 2013 | Tuesday | News
BMS to develop novel therapies for Parkinsons' disease

Singapore: Vanderbilt University, US, and Bristol-Myers Squibb signed a collaboration agreement for the R&D and comm...

September 25, 2012 | Tuesday | News
Glenmark receives two ANDA approvals from the FDA

Glenmark Pharmaceuticals USA (Glenmark) has been granted final approval by the United States Food and Drug Administratio...

March 29, 2016 | Tuesday | News
Researchers working on new drug for Lupus

Singapore: It has taken the lupus research community over 50 years to produce a new therapy. Although it is now a year o...

July 20, 2012 | Friday | Analysis
Stem cell therapy effective in liver cirrhosis

Singapore: A study conducted by Beike Biotechnology Company in conjunction with physicians and researchers at two Chines...

July 4, 2012 | Wednesday | News
Old drug gives hope for new treatment in autism

Singapore: Autism results from abnormal cell communication. Testing a new theory, researchers at the University of Calif...

March 15, 2013 | Friday | News